Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Interdependence between an expression of the ATG9A gene and the BAX gene in colorectal cancer.

Gil J, Ramsey D, Pawlowski P, Szmida E, Leszczynski P, Bebenek M, Sasiadek MM.

J Biol Regul Homeost Agents. 2019 Jan-Feb,;33(1):183-185. No abstract available.

PMID:
30761869
2.

First-episode schizophrenia is associated with a reduction of HERV-K methylation in peripheral blood.

Mak M, Samochowiec J, Frydecka D, Pełka-Wysiecka J, Szmida E, Karpiński P, Sąsiadek MM, Piotrowski P, Samochowiec A, Misiak B.

Psychiatry Res. 2019 Jan;271:459-463. doi: 10.1016/j.psychres.2018.12.012. Epub 2018 Dec 3.

PMID:
30537669
3.

The Influence of Tumor Microenvironment on ATG4D Gene Expression in Colorectal Cancer Patients.

Gil J, Ramsey D, Pawlowski P, Szmida E, Leszczynski P, Bebenek M, Sasiadek MM.

Med Oncol. 2018 Oct 29;35(12):159. doi: 10.1007/s12032-018-1220-6.

4.

Novel de novo mutation affecting two adjacent aminoacids in the EED gene in a patient with Weaver syndrome.

Smigiel R, Biernacka A, Biela M, Murcia-Pienkowski V, Szmida E, Gasperowicz P, Kosinska J, Kostrzewa G, Koppolu AA, Walczak A, Wawrzuta D, Rydzanicz M, Sasiadek M, Ploski R.

J Hum Genet. 2018 Apr;63(4):517-520. doi: 10.1038/s10038-017-0391-x. Epub 2018 Feb 6. Review.

PMID:
29410511
5.

Polymorphisms in immune-inflammatory response genes and the risk of deficit schizophrenia.

Mak M, Misiak B, Frydecka D, Pełka-Wysiecka J, Kucharska-Mazur J, Samochowiec A, Bieńkowski P, Pawlak-Adamska E, Karabon L, Szmida E, Skiba P, Kotowicz K, Piotrowski P, Beszłej JA, Samochowiec J.

Schizophr Res. 2018 Mar;193:359-363. doi: 10.1016/j.schres.2017.06.050. Epub 2017 Jun 30.

PMID:
28673752
6.

The BAX gene as a candidate for negative autophagy-related genes regulator on mRNA levels in colorectal cancer.

Gil J, Ramsey D, Szmida E, Leszczynski P, Pawlowski P, Bebenek M, Sasiadek MM.

Med Oncol. 2017 Feb;34(2):16. doi: 10.1007/s12032-016-0869-y. Epub 2016 Dec 29.

7.

Genetic Variation in One-Carbon Metabolism and Changes in Metabolic Parameters in First-Episode Schizophrenia Patients.

Misiak B, Laczmanski L, Sloka NK, Szmida E, Slezak R, Piotrowski P, Kiejna A, Frydecka D.

Int J Neuropsychopharmacol. 2017 Mar 1;20(3):207-212. doi: 10.1093/ijnp/pyw094.

8.

Further evidence for GRIN2B mutation as the cause of severe epileptic encephalopathy.

Smigiel R, Kostrzewa G, Kosinska J, Pollak A, Stawinski P, Szmida E, Bloch M, Szymanska K, Karpinski P, Sasiadek MM, Ploski R.

Am J Med Genet A. 2016 Dec;170(12):3265-3270. doi: 10.1002/ajmg.a.37887. Epub 2016 Sep 8.

PMID:
27605359
9.

Metabolic dysregulation in first-episode schizophrenia patients with respect to genetic variation in one-carbon metabolism.

Misiak B, Łaczmański Ł, Słoka NK, Szmida E, Piotrowski P, Loska O, Ślęzak R, Kiejna A, Frydecka D.

Psychiatry Res. 2016 Apr 30;238:60-67. doi: 10.1016/j.psychres.2016.01.077. Epub 2016 Feb 10.

PMID:
27086212
10.

Lower LINE-1 methylation in first-episode schizophrenia patients with the history of childhood trauma.

Misiak B, Szmida E, Karpiński P, Loska O, Sąsiadek MM, Frydecka D.

Epigenomics. 2015;7(8):1275-85. doi: 10.2217/epi.15.68. Epub 2015 Jul 27.

11.

Hexasomy 13q31.3q34 due to two marker chromosomes with inverted duplication in a fetus with increased nuchal translucency.

Stembalska A, Jagielska G, Laczmanska I, Szmida E, Jarczynska A, Gil J.

Birth Defects Res A Clin Mol Teratol. 2015 Apr;103(4):255-9. doi: 10.1002/bdra.23344. Epub 2015 Apr 7.

PMID:
25852029
12.

A TMC1 (transmembrane channel-like 1) mutation (p.S320R) in a Polish family with hearing impairment.

Hassan MA, Shah AA, Szmida E, Smigiel R, Sasiadek MM, Pfister M, Blin N, Bress A.

J Appl Genet. 2015 Aug;56(3):311-6. doi: 10.1007/s13353-014-0263-4. Epub 2015 Jan 6.

PMID:
25560804
13.

Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.

Szmida E, Karpiński P, Leszczynski P, Sedziak T, Kielan W, Ostasiewicz P, Sasiadek MM.

J Appl Genet. 2015 May;56(2):185-92. doi: 10.1007/s13353-014-0253-6. Epub 2014 Nov 1.

14.

Intermediate- and low-methylation epigenotypes do not correspond to CpG island methylator phenotype (low and -zero) in colorectal cancer.

Karpinski P, Walter M, Szmida E, Ramsey D, Misiak B, Kozlowska J, Bebenek M, Grzebieniak Z, Blin N, Laczmanski L, Sasiadek MM.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):201-8. doi: 10.1158/1055-9965.EPI-12-0157. Epub 2012 Nov 21.

15.

Protein tyrosine phosphatase receptor-like genes are frequently hypermethylated in sporadic colorectal cancer.

Laczmanska I, Karpinski P, Bebenek M, Sedziak T, Ramsey D, Szmida E, Sasiadek MM.

J Hum Genet. 2013 Jan;58(1):11-5. doi: 10.1038/jhg.2012.119. Epub 2012 Oct 25.

PMID:
23096495
16.

Assessment of chromosomal imbalances in CIMP-high and CIMP-low/CIMP-0 colorectal cancers.

Kozlowska J, Karpinski P, Szmida E, Laczmanska I, Misiak B, Ramsey D, Bebenek M, Kielan W, Pesz KA, Sasiadek MM.

Tumour Biol. 2012 Aug;33(4):1015-9. doi: 10.1007/s13277-012-0334-2. Epub 2012 Jan 25.

PMID:
22274926
17.

Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.

Karpinski P, Szmida E, Misiak B, Ramsey D, Leszczynski P, Bebenek M, Sedziak T, Grzebieniak Z, Jonkisz A, Lebioda A, Sasiadek MM.

Mol Carcinog. 2012 Dec;51(12):1003-8. doi: 10.1002/mc.20871. Epub 2011 Oct 17.

PMID:
22006538
18.

Irrelevance of CHEK2 variants to diagnosis of breast/ovarian cancer predisposition in Polish cohort.

Myszka A, Karpinski P, Slezak R, Czemarmazowicz H, Stembalska A, Gil J, Laczmanska I, Bednarczyk D, Szmida E, Sasiadek MM.

J Appl Genet. 2011 May;52(2):185-91. doi: 10.1007/s13353-010-0013-1. Epub 2010 Dec 1.

PMID:
21120647

Supplemental Content

Loading ...
Support Center